Tivic Health To Report First Quarter 2023 Financial Results on May 15th Via Conference Call and Webcast
11 Maio 2023 - 10:30AM
Business Wire
Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a
health tech company that develops and commercializes bioelectronic
medicine, today announced that it will report financial results for
the first quarter 2023 via a pre-recorded conference call and
webcast on Monday, May 15th, 2023 at 1:30 pm PT / 4:30 pm ET.
Teleconference Details: Toll Free: 877-545-0523
International: 973-528-0016 Participant Access Code: 888610
Webcast Link
https://www.webcaster4.com/Webcast/Page/2865/48259
Shareholders also may submit questions in advance of the
earnings call by sending them to the following email address -
ir@tivichealth.com. The deadline for submitting questions in
advance of the webcast/conference call is 5:00 PM ET on May 11th,
2023. Due to time constraints and the nature of the questions
please be advised that not all questions submitted can be
answered.
About Tivic
Tivic is a commercial health tech company advancing the field of
bioelectronic medicine. Tivic’s patented technology platform
leverages stimulation on the trigeminal, sympathetic, and vagus
nerve structures. Tivic’s non-invasive and targeted approach to the
treatment of inflammatory chronic health conditions gives consumers
and providers drug-free therapeutic solutions with high safety
profiles, low risk, and broad applications. Tivic’s first
commercial product ClearUP is an FDA approved, award-winning,
handheld bioelectronic sinus device. ClearUP is clinically proven,
doctor-recommended, and is available through online retailers and
commercial distributors. For more information visit
http://tivichealth.com @TivicHealth
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors. Given
these risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. For a discussion of
risks and uncertainties relevant to the company, and other
important factors, any of which could cause Tivic’s actual results
to differ from those contained in the forward-looking statements,
see Tivic’s filings with the SEC, including, its Annual Report on
Form 10-K for the year ended December 31, 2022, filed with the SEC
on March 31, 2023, under the heading “Risk Factors”, as well as the
company’s subsequent filings with the SEC. Forward-looking
statements contained in this press release are made as of this
date, and Tivic Health Systems, Inc. undertakes no duty to update
such information except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230511005347/en/
Media Contact: Kayleigh Westerfield 949-632-3439
Kayleigh.Westerfield@tivichealth.com
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024